Page last updated: 2024-09-02

fingolimod hydrochloride and hydroxychloroquine

fingolimod hydrochloride has been researched along with hydroxychloroquine in 3 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(hydroxychloroquine)
Trials
(hydroxychloroquine)
Recent Studies (post-2010) (hydroxychloroquine)
2,7711572,0625,8854744,041

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)hydroxychloroquine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)2.951
Alpha-1D adrenergic receptorHomo sapiens (human)4.772
Toll-like receptor 9Homo sapiens (human)0.11
Toll-like receptor 7Homo sapiens (human)3.4

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Ekobena, P; Ivanyuk, A; Livio, F1
Hiramoto, M; Hirota, A; Kazama, H; Miyazaki, M; Miyazawa, K; Ogawa, M; Ota, K; Suzuki, S; Takano, N1
Ahmed, A; Carol, HA; Ochfeld, EN1

Reviews

1 review(s) available for fingolimod hydrochloride and hydroxychloroquine

ArticleYear
[Pharmacovigilance update].
    Revue medicale suisse, 2021, Jan-13, Volume: 17, Issue:720-1

    Topics: Adenosine Monophosphate; Alanine; Cleft Lip; Contraindications, Drug; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Leiomyoma; Norpregnadienes; Pharmacokinetics; Pharmacovigilance; Pregnancy; Ranitidine; Safety-Based Drug Withdrawals; Skin Neoplasms

2021

Other Studies

2 other study(ies) available for fingolimod hydrochloride and hydroxychloroquine

ArticleYear
Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.
    Oncology reports, 2022, Volume: 47, Issue:2

    Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Lapatinib; Lysosomes; Pancreatic Neoplasms; Sphingosine 1 Phosphate Receptor Modulators

2022
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management.
    Immunologic research, 2022, Volume: 70, Issue:5

    Topics: Actins; Azathioprine; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Infliximab; Lymphopenia; Mitogens; Neonatal Screening; Receptors, Antigen, T-Cell; Severe Combined Immunodeficiency; Vaccines

2022